Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China

Fengyi Hao,Bokun Wang,Wanqiu Tan,Syeda Fabeha Husain,Roger S. McIntyre,Xiangdong Tang,Ling Zhang,Xiaofan Han,Li Jiang,Nicholas W. S. Chew,Benjamin Yong-Qiang Tan,Bach Tran,Zhisong Zhang,Gia Linh Vu,Giang Thu Vu,Roger Ho,Cyrus S. Ho,Vijay K. Sharma
DOI: https://doi.org/10.1192/bjo.2021.979
2021-08-11
BJPsych Open
Abstract:Background Acceptance and willingness to pay for the COVID-19 vaccine are unknown. Aims We compared attitudes toward COVID-19 vaccination in people suffering from depression or anxiety disorder and people without mental disorders, and their willingness to pay for it. Method Adults with depression or anxiety disorder ( n = 79) and healthy controls ( n = 134) living in Chongqing, China, completed a cross-sectional study between 13 and 26 January 2021. We used a validated survey to assess eight aspects related to attitudes toward the COVID-19 vaccines. Psychiatric symptoms were assessed by the 21-item Depression, Anxiety and Stress Scale. Results Seventy-six people with depression or anxiety disorder (96.2%) and 134 healthy controls (100%) reported willingness to receive the COVID-19 vaccine. A significantly higher proportion of people with depression or anxiety disorder (64.5%) were more willing to pay for the COVID-19 vaccine than healthy controls (38.1%) ( P ≤ 0.001). After multivariate adjustment, severity of depression and anxiety was significantly associated with willingness to pay for COVID-19 vaccination among psychiatric patients ( P = 0.048). Non-healthcare workers ( P = 0.039), health insurance ( P = 0.003), living with children ( P = 0.006) and internalised stigma ( P = 0.002) were significant factors associated with willingness to pay for COVID-19 vaccine in healthy controls. Conclusions To conclude, psychiatric patients in Chongqing, China, showed high acceptance and willingness to pay for the COVID-19 vaccine. Factors associated with willingness to pay for the COVID-19 vaccine differed between psychiatric patients and healthy controls.
psychiatry
What problem does this paper attempt to address?